Πέμπτη 2 Νοεμβρίου 2017

Inhibition of ABCC4 potentiates combination beta agonist and glucocorticoid responses in human airway epithelial cells

ABCC4 inhibition potentiates cAMP signaling and the effect of glucocorticoids at the genomic and functional level, with implications for future asthma management.

http://ift.tt/2z8yPN1

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου